The recently passed federal defense budget for 2026 includes dedicated funding for the use of bioengineered blood vessels ...
"Deepening our relationship with Wake Forest University School of Medicine validates applications for medical foods, adds depth and capability to the PBI team, and accelerates sales through faster ...
The GXP site feeds into a surge of biomanufacturing activity in the state’s Eastern Region. The region scored $7.1 billion of the state's $10.8 billion in new life sciences investments announced in ...
Life sciences companies from around the globe continued to favor North Carolina for both new sites and expanded operations in ...
AskBio Inc., an RTP-based gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has received U.S. Food and Drug Administration (FDA) acceptance of its ...
The Traits Company, an agricultural biotechnology company headquartered in Research Triangle Park, has announced a strategic collaboration with U.K.-based Wild Bioscience to accelerate the development ...
Life sciences industry representatives in North Carolina will experience NCBioImpact as an interconnected coalition of multiple academic institutions that provide skilled resources to the life ...
NCBiotech's event and meeting grants support North Carolina-based events and meetings that bring information and networking opportunities on diverse topics to the life sciences community statewide.
The Translational Research Grant (TRG) program funds research projects that explore commercial applications or initiate the early commercial development of university-held life sciences inventions.
Turning ideas into impactful solutions can be a hit-or-miss proposition. To get more agricultural technology hits, the new North Carolina Plant Sciences Initiative (N.C. PSI) Startup Program helps ...
Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is back on track with a potential drug to treat rapid heart rates in certain cardiovascular disorders. The company in ...